Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Acta Neurochir (Wien). 2024 Nov 18;166(1):460. doi: 10.1007/s00701-024-06332-3.
Posterior fossa decompression for Chiari malformation type I (Chiari 1) is effective and associated with a low risk of complication. However, up to 20% of patients may experience continued deficits or recurring symptoms after surgical intervention. For pediatric patients, there are no established tools to predict outcomes, and the risk factors for unfavorable postoperative outcomes are poorly understood. Hence, our aim was to investigate baseline data and early postoperative predictors of poor outcomes as determined by the Chicago Chiari outcome scale (CCOS).
All pediatric patients (< 18 years) receiving a posterior fossa decompression for Chiari 1 between the years of 2005 and 2020 at the study center were eligible for inclusion. Patients with congenital anomalies were excluded.
Seventy-one pediatric patients with a median age of 9 years were included. Most patients (58%) were females. Chiari 1 was associated with syringomyelia (51%), scoliosis (37%), and hydrocephalus (7%). Perioperative complications occurred in 13 patients (18%) of which two required additional procedures under general anesthesia. On multivariable proportional odds logistic regression, motor deficits (OR: 0.09; CI95%: [0.01-0.62]; p = 0.015), and surgical complications (OR: 0.16; CI95%: [0.41-0.66]; p = 0.011) were significant predictors of worse outcomes. The presence of syringomyelia was identified as a predictor of better outcomes (OR: 4.42 CI95% [1.02-19.35]; p = 0.048). A persistent hydrocephalus during the early postoperative period after posterior fossa decompression was a strong predictor of worse long-term CCOS (OR: 0.026; CI95%: [0.002-0.328]; p = 0.005).
Results from this study indicate that the existence of motor deficits and syringomyelia prior to surgery, and surgical complications and persistent hydrocephalus despite posterior fossa decompression, were useful predictors of long-term outcome.
颅后窝减压术治疗 Chiari 畸形 I 型(Chiari 1)有效,且并发症风险低。然而,多达 20%的患者在手术干预后可能会持续出现缺陷或症状复发。对于儿科患者,目前还没有确定的工具来预测手术结果,并且对不良术后结局的危险因素了解甚少。因此,我们的目的是通过芝加哥 Chiari 结局量表(CCOS)调查基线数据和术后早期预测不良结局的因素。
研究中心在 2005 年至 2020 年间对所有接受 Chiari 1 颅后窝减压术的儿科患者(<18 岁)进行了回顾性研究。患有先天性畸形的患者被排除在外。
研究共纳入了 71 例中位年龄为 9 岁的儿科患者。大多数患者(58%)为女性。Chiari 1 与脊髓空洞症(51%)、脊柱侧凸(37%)和脑积水(7%)有关。13 例患者(18%)发生围手术期并发症,其中 2 例需在全身麻醉下进行额外手术。多变量比例优势逻辑回归分析显示,运动功能障碍(OR:0.09;95%CI:[0.01-0.62];p=0.015)和手术并发症(OR:0.16;95%CI:[0.41-0.66];p=0.011)是预后不良的显著预测因素。存在脊髓空洞症被确定为预后较好的预测因素(OR:4.42,95%CI [1.02-19.35];p=0.048)。颅后窝减压术后早期持续存在脑积水是 CCOS 长期预后不良的强烈预测因素(OR:0.026;95%CI:[0.002-0.328];p=0.005)。
本研究结果表明,手术前存在运动功能障碍和脊髓空洞症,以及手术并发症和颅后窝减压术后持续存在脑积水,是长期预后的有用预测因素。